Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Purinergic P2Y Eurofins Panlabs panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
Antagonist activity at mouse P2Y2
Agonist activity at human P2Y2
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Agonist activity at human P2Y2 transfected in human 1321N1 cells
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
Antagonist activity at human P2Y2R expressed in human 1321N1 cells assessed as inhibition of UDP-induced calcium mobilization at 100 uM by FLIPR assay relative to control
Assay data:5 Tested
Selectivity interaction (GPCR panel (Eurofins-Cerep)) EUB0000333a P2RY2
Antagonist activity at P2Y2R (unknown origin) expressed in human 1321N1 cells assessed as inhibition of forskolin-stimulated cAMP accumulation incubated for 15 mins in presence of IBMX by chromatography
SummaryPubMed CitationRelated BioAssays by Target
Purinergic P2Y Eurofins-Panlabs radioligand binding assay
Assay data:4 Tested
Assay data:9 Tested
P2Y2 Eurofins Bayer panel
PRESTO-Tango GPCRome screening (P2RY2)
P2Y2 (h) Eurofins-Cerep Cellular and Nuclear Receptor Functional Assays
P2Y CEREP ligand profiling
P2Y-purinergic receptor CEREP ligand profiling
P2Y Ligand binding assay
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on